Compare Avantis (AVNT) vs Enzyme (MLN) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Avantis vs Enzyme — how do they compare? Avantis trades at Rp1,704 (market cap Rp561,82M, Rp472,02M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Avantis is far larger — about 4.2× Enzyme's market cap, and Avantis's supply is capped (329,1M / 1B AVNT (33%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Avantis for 19 Days and Enzyme for 28 Days on average.
| AVNT | MLN | |
|---|---|---|
Market Cap | Rp561,82M | Rp134,13M |
Volume (24h) | Rp472,02M | Rp104,56M |
Circulating Supply | 329,1M / 1B AVNT (33%) | 3,3M MLN |
Typical Hold Time | 19 Days | 28 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Avantis (AVNT) is currently trading at Rp1,666, showing bearish technical signals with all moving averages indicating sell. The token has a market cap of Rp542.78 million and a circulating supply of 329.1 million out of 1 million max supply, indicating a high circulation rate of 33%. Recent on-chain activity shows an average hold time of 19 days, suggesting moderate trader turnover. Support levels are found at Rp1,490 (S3) and Rp1,575 (S2), while resistance lies at Rp1,752 (R1) and Rp1,837 (R2).
Overall outlook remains cautious due to strong bearish technical indicators and limited fundamental developments. Key opportunities include potential rebounds from support zones, but risks involve low liquidity and high volatility. Investors should monitor exchange volume and network updates for signs of renewed interest.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134.13 million and circulating supply of 3.3 million tokens. The asset demonstrates relatively low volatility with a 28-day average hold time, suggesting stable holding patterns among current investors. Trading volumes appear subdued, indicating limited market participation and liquidity depth at current levels.
Overall outlook remains cautious due to thin liquidity and limited ecosystem developments. Key opportunities include potential protocol upgrades and ecosystem expansion, while major risks center around low trading volumes and regulatory uncertainty in the cryptocurrency space. Investors should monitor network activity and exchange listings for catalysts.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Avantis
Avantis is the largest RWA perpetuals DEX in DeFi, built on Base. It enables users to trade crypto and real-world assets such as FX, commodities, indices, and equities. Supported by Pantera and Coinbase, Avantis combines institutional-grade products with the transparency and accessibility of DeFi, offering leverage up to 500x.
Read more on AVNT →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
